
China Health Group Announces Board Composition and Committee Roles

I'm PortAI, I can summarize articles.
China Health Group (HK:0673) has announced its board composition and committee roles, detailing the executive, non-executive, and independent non-executive directors, along with the members and chairpersons of its audit, nomination, and remuneration committees. This update clarifies the company's governance structure, which may influence its strategic direction. The current analyst rating for the stock is a Hold with a price target of HK$0.50, and the market cap stands at HK$669.6M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

